FDA | What's New
Follow
Lessons Learned from our Roundtable with Rare Disease Advocates
Recently FDA leadership held a roundtable discussion with 15 dedicated rare disease leaders. Hearing directly from patients and family members who navigate these incredibly challenging conditions every day was both grounding and motivating.
